CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase

The research leading to these results has mainly received funding from the European Union Seventh Framework Programme [FP7/2007–2013] under Grant Agreement no 306242-NGS-PTL. In addition, this work was supported by grants from the Spanish Fondo de Investigaciones Sanitarias PI15/01471, PI18/01500, I...

ver descrição completa

Detalhes bibliográficos
Autores: Hernández-Sánchez, María, Kotaskova, Jana, Rodríguez, Ana E., Radova, Lenka, Tamborero Noguera, David, Abáigar, María, Plevova, Karla, Benito, Rocío, Tom, Nikola, Quijada-Álamo, Miguel, Bikos, Vasileos, Martín, Ana África, Pal, Karol, García de Coca, Alfonso, Doubek, Michael, López Bigas, Núria, Hernández-Rivas, Jesús María, Pospisilova, Sarka
Formato: artículo
Estado:Versión publicada
Fecha de publicación:2019
País:España
Recursos:Universitat Pompeu Fabra
Repositorio:Repositorio Digital de la UPF
OAI Identifier:oai:repositori.upf.edu:10230/41729
Acesso em linha:http://hdl.handle.net/10230/41729
http://dx.doi.org/10.1038/s41375-018-0255-1
Access Level:acceso abierto
Palavra-chave:Leucèmia
id ES_2e7b352ed6cdc3537e0aa9fdff2a7891
oai_identifier_str oai:repositori.upf.edu:10230/41729
network_acronym_str ES
network_name_str España
repository_id_str
dc.title.none.fl_str_mv CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
title CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
spellingShingle CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
Hernández-Sánchez, María
Leucèmia
title_short CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
title_full CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
title_fullStr CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
title_full_unstemmed CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
title_sort CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phase
dc.creator.none.fl_str_mv Hernández-Sánchez, María
Kotaskova, Jana
Rodríguez, Ana E.
Radova, Lenka
Tamborero Noguera, David
Abáigar, María
Plevova, Karla
Benito, Rocío
Tom, Nikola
Quijada-Álamo, Miguel
Bikos, Vasileos
Martín, Ana África
Pal, Karol
García de Coca, Alfonso
Doubek, Michael
López Bigas, Núria
Hernández-Rivas, Jesús María
Pospisilova, Sarka
author Hernández-Sánchez, María
author_facet Hernández-Sánchez, María
Kotaskova, Jana
Rodríguez, Ana E.
Radova, Lenka
Tamborero Noguera, David
Abáigar, María
Plevova, Karla
Benito, Rocío
Tom, Nikola
Quijada-Álamo, Miguel
Bikos, Vasileos
Martín, Ana África
Pal, Karol
García de Coca, Alfonso
Doubek, Michael
López Bigas, Núria
Hernández-Rivas, Jesús María
Pospisilova, Sarka
author_role author
author2 Kotaskova, Jana
Rodríguez, Ana E.
Radova, Lenka
Tamborero Noguera, David
Abáigar, María
Plevova, Karla
Benito, Rocío
Tom, Nikola
Quijada-Álamo, Miguel
Bikos, Vasileos
Martín, Ana África
Pal, Karol
García de Coca, Alfonso
Doubek, Michael
López Bigas, Núria
Hernández-Rivas, Jesús María
Pospisilova, Sarka
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Leucèmia
topic Leucèmia
description The research leading to these results has mainly received funding from the European Union Seventh Framework Programme [FP7/2007–2013] under Grant Agreement no 306242-NGS-PTL. In addition, this work was supported by grants from the Spanish Fondo de Investigaciones Sanitarias PI15/01471, PI18/01500, Instituto de Salud Carlos III (ISCIII), European Regional Development Fund (ERDF) “Una manera de hacer Europa”, “Consejería de Educación, Junta de Castilla y León” (SA085U16), “Proyectos de Investigación del SACYL”, Spain: GRS 994/A/14, BIO/SA10/14, BIO/SA31/13, GRS 1172/A/15,“Fundación Memoria Don Samuel Solórzano Barruso”, by grants (RD12/0036/0069) from Red Temática de Investigación Cooperativa en Cáncer (RTICC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) CB16/12/00233 and USAL "Programa XIII". M. Hernández-Sánchez is supported by FEHH-Janssen (“Sociedad Española de Hematología y Hemoterapia”). M Quijada-Álamo is supported by an “Ayuda Predoctoral de la Junta de Castilla y León” (JCYL-EDU/529/2017). We are grateful to I. Rodríguez, S. González, T.Prieto, M. Á. Ramos, A. Martín, A. Díaz, A. Simón, M.del Pozo, V. Gutiérrez and S. Pujante from Centro de Investigación del Cáncer, Salamanca, for their technical assistance. D. Tamborero is supported by project SAF2015–74072-JUN, which is funded by the Agencia Estatal de Investigación (AEI) and Fondo Europeo de Dearrollo Regional (FEDER). This work was supported by Seventh Framework Programme (NGS-PTL/2012–2015/no.306242) and Ministry of Education, Youth and Sports (2013–2015, no. 7E13008); by the Ministry of Education, Youth and Sports of the Czech Republic under the CEITEC 2020 project (LQ1601); by the Ministry of Health, Czech Republic - conceptual development of research organization (FNBr, 65269705); by the Specific University Research (nr. MUNI/A/0968/2017) provided by MEYS; and by the project CZ.02.1.01/0.0/0.0/16_013/0001634 National Center for Medical Genomic - modernization of infrastructure and research of genetic variation in the population, funded by OP RDE. We acknowledge the CF Genomics CEITEC MU supported by the NCMG research infrastructure (LM2015091 funded by MEYS CR) for their support with obtaining the scientific data presented in this paper. We acknowledge S. Takacova from CEITEC MU for her help with the sample selection and processing.
publishDate 2019
dc.date.none.fl_str_mv 2019
2019
2019
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/10230/41729
http://dx.doi.org/10.1038/s41375-018-0255-1
url http://hdl.handle.net/10230/41729
http://dx.doi.org/10.1038/s41375-018-0255-1
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Leukemia. 2019 Feb;33(2):518-58
info:eu-repo/grantAgreement/EC/FP7/306242
info:eu-repo/grantAgreement/ES/1PE/SAF2015–74072-JUN
info:eu-repo/grantAgreement/EC/FP7/306242
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv Nature Research
publisher.none.fl_str_mv Nature Research
dc.source.none.fl_str_mv reponame:Repositorio Digital de la UPF
instname:Universitat Pompeu Fabra
instname_str Universitat Pompeu Fabra
reponame_str Repositorio Digital de la UPF
collection Repositorio Digital de la UPF
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869405407820120064
spelling CLL cells cumulate genetic aberrations prior to the first therapy even in outwardly inactive disease phaseHernández-Sánchez, MaríaKotaskova, JanaRodríguez, Ana E.Radova, LenkaTamborero Noguera, DavidAbáigar, MaríaPlevova, KarlaBenito, RocíoTom, NikolaQuijada-Álamo, MiguelBikos, VasileosMartín, Ana ÁfricaPal, KarolGarcía de Coca, AlfonsoDoubek, MichaelLópez Bigas, NúriaHernández-Rivas, Jesús MaríaPospisilova, SarkaLeucèmiaThe research leading to these results has mainly received funding from the European Union Seventh Framework Programme [FP7/2007–2013] under Grant Agreement no 306242-NGS-PTL. In addition, this work was supported by grants from the Spanish Fondo de Investigaciones Sanitarias PI15/01471, PI18/01500, Instituto de Salud Carlos III (ISCIII), European Regional Development Fund (ERDF) “Una manera de hacer Europa”, “Consejería de Educación, Junta de Castilla y León” (SA085U16), “Proyectos de Investigación del SACYL”, Spain: GRS 994/A/14, BIO/SA10/14, BIO/SA31/13, GRS 1172/A/15,“Fundación Memoria Don Samuel Solórzano Barruso”, by grants (RD12/0036/0069) from Red Temática de Investigación Cooperativa en Cáncer (RTICC), Centro de Investigación Biomédica en Red de Cáncer (CIBERONC) CB16/12/00233 and USAL "Programa XIII". M. Hernández-Sánchez is supported by FEHH-Janssen (“Sociedad Española de Hematología y Hemoterapia”). M Quijada-Álamo is supported by an “Ayuda Predoctoral de la Junta de Castilla y León” (JCYL-EDU/529/2017). We are grateful to I. Rodríguez, S. González, T.Prieto, M. Á. Ramos, A. Martín, A. Díaz, A. Simón, M.del Pozo, V. Gutiérrez and S. Pujante from Centro de Investigación del Cáncer, Salamanca, for their technical assistance. D. Tamborero is supported by project SAF2015–74072-JUN, which is funded by the Agencia Estatal de Investigación (AEI) and Fondo Europeo de Dearrollo Regional (FEDER). This work was supported by Seventh Framework Programme (NGS-PTL/2012–2015/no.306242) and Ministry of Education, Youth and Sports (2013–2015, no. 7E13008); by the Ministry of Education, Youth and Sports of the Czech Republic under the CEITEC 2020 project (LQ1601); by the Ministry of Health, Czech Republic - conceptual development of research organization (FNBr, 65269705); by the Specific University Research (nr. MUNI/A/0968/2017) provided by MEYS; and by the project CZ.02.1.01/0.0/0.0/16_013/0001634 National Center for Medical Genomic - modernization of infrastructure and research of genetic variation in the population, funded by OP RDE. We acknowledge the CF Genomics CEITEC MU supported by the NCMG research infrastructure (LM2015091 funded by MEYS CR) for their support with obtaining the scientific data presented in this paper. We acknowledge S. Takacova from CEITEC MU for her help with the sample selection and processing.Nature Research201920192019info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfapplication/pdfhttp://hdl.handle.net/10230/41729http://dx.doi.org/10.1038/s41375-018-0255-1reponame:Repositorio Digital de la UPFinstname:Universitat Pompeu FabraInglésLeukemia. 2019 Feb;33(2):518-58info:eu-repo/grantAgreement/EC/FP7/306242info:eu-repo/grantAgreement/ES/1PE/SAF2015–74072-JUNinfo:eu-repo/grantAgreement/EC/FP7/306242This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/info:eu-repo/semantics/openAccessoai:repositori.upf.edu:10230/417292026-06-12T07:21:37Z
score 15.812429